Mirae Asset Global Investments Co. Ltd. Makes New Investment in Danaher Corporation $DHR

Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 214,671 shares of the conglomerate’s stock, valued at approximately $47,560,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Main Street Group LTD acquired a new stake in shares of Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter valued at about $25,000. Marquette Asset Management LLC grew its stake in shares of Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 73 shares during the last quarter. Evolution Wealth Management Inc. increased its stake in shares of Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after buying an additional 104 shares during the period. Finally, Field & Main Bank bought a new stake in Danaher during the 2nd quarter worth about $29,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DHR has been the topic of a number of analyst reports. The Goldman Sachs Group reiterated a “buy” rating and issued a $275.00 price target on shares of Danaher in a research report on Thursday, October 22nd. Barclays increased their target price on shares of Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Citigroup upped their price objective on shares of Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Finally, Royal Bank Of Canada lifted their target price on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Trading Down 0.0%

NYSE DHR opened at $232.22 on Monday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. The stock has a 50 day moving average of $218.92 and a 200-day moving average of $201.77. The company has a market cap of $163.37 billion, a PE ratio of 38.01, a PEG ratio of 2.92 and a beta of 0.76.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.89 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.

Insider Transactions at Danaher

In related news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 10.80% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.